Kiernan Colleen M, Du Liping, Chen Xi, Broome James T, Shi Chanjuan, Peters Mary F, Solorzano Carmen C
Department of General Surgery, Vanderbilt University, Nashville, TN, USA,
Ann Surg Oncol. 2014 Nov;21(12):3865-71. doi: 10.1245/s10434-014-3847-7. Epub 2014 Jun 18.
Resection of pheochromocytoma is often associated with hemodynamic instability (HDI). We examined patient and tumor factors that may influence HDI. The effect of pretreatment with nonselective α blockade phenoxybenzamine (PXB) versus selective α blockade on HDI and outcomes was also evaluated.
The records of 91 patients who underwent adrenalectomy between 2002 and 2013 were retrospectively reviewed. HDI was determined by number of intraoperative episodes of systolic blood pressure (SBP) > 200 mmHg, those greater than or less than 30 % of baseline, heart rate > 110 bpm, and the need for postoperative vasopressors. Fishers exact, t test and regressions were performed.
Among 91 patients, 78 % received PXB, 18 % selective α blockade and 4 % no adrenergic blockade. Patient demographics, tumor factors and surgical approach were similar among the blockade groups. On multivariate analysis, increasing tumor size was associated with a significant rise in the number of episodes of SBP > 30 % [rate ratio (RR) 1.40] and an increased postoperative vasopressor requirement [odds ratio (OR) 1.23]. Open adrenalectomy and use of selective blockade were associated with an increased number of episodes of SBP > 200 mmHg (RR 27.8 and RR 20.9, respectively). Open adrenalectomy was also associated with increased readmissions (OR 12.3), complications (OR 5.6), use of postoperative vasopressors (OR 4.4) and hospital stay (4.6 days longer). There were no differences in other HDI measurements or postoperative outcomes among the blockade groups.
Tumor size, open adrenalectomy, and type of α blockade were associated with intraoperative HDI during pheochromocytoma resection. Selective blockade was associated with significantly more episodes of intraoperative hypertension but no perioperative adverse outcomes.
嗜铬细胞瘤切除术常伴有血流动力学不稳定(HDI)。我们研究了可能影响HDI的患者因素和肿瘤因素。还评估了非选择性α受体阻滞剂酚苄明(PXB)预处理与选择性α受体阻滞剂对HDI及预后的影响。
回顾性分析2002年至2013年间接受肾上腺切除术的91例患者的病历。HDI通过术中收缩压(SBP)>200 mmHg发作次数、高于或低于基线30%的次数、心率>110次/分发作次数以及术后使用血管升压药的情况来确定。进行了Fisher精确检验、t检验和回归分析。
91例患者中,78%接受了PXB,18%接受了选择性α受体阻滞剂,4%未接受肾上腺素能阻滞剂。各阻滞剂组患者的人口统计学特征、肿瘤因素和手术方式相似。多因素分析显示,肿瘤大小增加与SBP>30%发作次数显著增加[率比(RR)1.40]及术后血管升压药需求增加[比值比(OR)1.23]相关。开放性肾上腺切除术和使用选择性阻滞剂与SBP>200 mmHg发作次数增加相关(RR分别为27.8和20.9)。开放性肾上腺切除术还与再入院率增加(OR 12.3)、并发症(OR 5.6)、术后血管升压药使用(OR 4.4)及住院时间延长(延长4.6天)相关。各阻滞剂组在其他HDI指标或术后预后方面无差异。
肿瘤大小、开放性肾上腺切除术及α受体阻滞剂类型与嗜铬细胞瘤切除术中的术中HDI相关。选择性阻滞剂与术中高血压发作次数显著增多相关,但无围手术期不良后果。